ArticleScience progress
Association of admission lactate dehydrogenase-to-albumin ratio with acute pancreatitis recurrence after first-episode hypertriglyceridemia-induced acute pancreatitis: A multicenter retrospective cohort study.
Article in Science progress. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
ObjectiveHypertriglyceridemia-induced acute pancreatitis (HTG-AP) has a high recurrence rate, and recurrent episodes may result in repeated hospitalizations and long-term pancreatic complications. Simple admission-based markers for recurrence stratification remain limited. This study examined whether admission lactate dehydrogenase-to-albumin ratio (LAR) was associated with recurrence after first-episode HTG-AP.MethodsThis multicenter retrospective cohort study included consecutive patients with first-episode HTG-AP admitted to three tertiary hospitals between January 2020 and March 2025. Admission LAR was calculated as lactate dehydrogenase divided by serum albumin measured within 24 hours and categorized into tertiles. The primary outcome was recurrent acute pancreatitis during follow-up, defined as a new episode at least 3 months after remission of the index episode. Follow-up was censored at the last valid follow-up date or June 30, 2025. Associations were assessed using Cox models, restricted cubic splines, negative binomial regression, subgroup analyses, and propensity score overlap weighting.ResultsA total of 240 patients were included; the median age was 39 years, and 83.3% were male. During a median follow-up of 15.5 months (IQR, 8.0-27.0), 70 patients (29.17%) experienced recurrence, with a median recurrence interval of 9.5 months (IQR, 3.0-12.8). In the fully adjusted Cox model, higher LAR was associated with recurrence as a continuous variable (HR per unit increase, 1.05; 95% CI, 1.02-1.08; P = 0.002). The highest versus lowest LAR tertile was associated with higher recurrence hazard (HR, 2.62; 95% CI, 1.31-5.25; P = 0.007). Higher LAR was also associated with greater recurrence burden (IRR, 1.08; 95% CI, 1.04-1.11; P < 0.001). Subgroup and sensitivity analyses showed generally consistent findings.ConclusionsAdmission LAR was associated with recurrence and recurrence burden in patients with first-episode HTG-AP. As a simple and available admission-based marker, LAR may help identify patients who warrant closer post-discharge monitoring, although prospective validation is needed.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.